---
title: "APA Schizophrenia"
organization: "American Psychiatric Association"
year: 2020
---

# APA Practice Guideline for the Treatment of Patients With Schizophrenia (2020)

## Pharmacotherapy
- **First-line**: Treat with an antipsychotic medication. 
- Selection should depend on side effect profile and patient preference.
- Clozapine is recommended for treatment-resistant schizophrenia (failure of 2 adequate trials).

## Long-Acting Injectables (LAIs)
- recommended for patients with poor adherence.
- Should be offered to all patients.

## Psychosocial Interventions
- CBT for psychosis (CBT-p)
- Family intervention
- Supported employment services
- Assertive Community Treatment (ACT) for high service users.

## Metabolic Monitoring
- Baseline: Weight, BMI, Waist Circumference, BP, Fasting Glucose, Lipid Profile.
- Monitor weight/BMI at every visit for 6 months, then quarterly.
- Monitor metabolic labs at 12 weeks, then annually.

## Citations
- Keepers GA, et al. Am J Psychiatry. 2020;177(9):868-872.
